Related Experiment Video
Updated: Feb 15, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Central Line-Associated Mucor velutinosus Bloodstream Infection in an Immunocompetent Pediatric Patient
Madan Kumar1, Barbara Jantausch1, Clarivet Torres2
1Pediatric Infectious Diseases, Microbiology Children's National Medical Center.
Abstract:
We report here the isolation of Mucor velutinosus from multiple blood cultures performed on samples from Broviac catheters and culture of a Broviac insertion-site wound sample from a 6-year-old boy with a history of intestinal failure secondary to chronic intestinal pseudo-obstruction, parenteral nutrition, and jejunostomy tube dependence. Examination of a slide from the culture revealed the presence of wide nonseptate hyphae with sporangiophores, columella, and chlamydospores. The fungal isolate was sent to the National Institutes of Health for further evaluation and was identified as Mucor velutinosus by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry and genomic sequencing. The patient was treated successfully with intravenous amphotericin B and prompt removal of his central line. To the best of our knowledge, this is the first case of M velutinosus bloodstream infection in a child without cancer.
Insights
This case study details the first reported instance of Mucor velutinosus bloodstream infection in a pediatric patient without cancer. The child recovered after treatment with amphotericin B and central line removal.
Area of Science:
- Mycology
- Infectious Diseases
- Pediatrics
Background:
- Mucor velutinosus is a fungus rarely implicated in human infections.
- Central venous catheters, such as Broviac catheters, are potential sources of fungal bloodstream infections in immunocompromised patients.
- Pediatric patients with intestinal failure often require long-term central venous access and parenteral nutrition, increasing infection risk.
Observation:
- A 6-year-old boy with intestinal failure experienced a bloodstream infection and wound infection at the Broviac catheter insertion site.
- Microscopic examination revealed characteristic fungal elements, including wide nonseptate hyphae, sporangiophores, columella, and chlamydospores.
- Identification was confirmed as Mucor velutinosus via mass spectrometry and genomic sequencing.
Findings:
- The patient presented with a bloodstream infection caused by Mucor velutinosus, a rare pathogen in this context.
- This represents the first documented case of Mucor velutinosus bloodstream infection in a pediatric patient without a cancer diagnosis.
- Successful treatment involved intravenous amphotericin B and removal of the infected central venous catheter.
Implications:
- Highlights the potential for Mucor velutinosus to cause serious infections in vulnerable pediatric populations.
- Emphasizes the importance of considering rare fungal pathogens in bloodstream infections, especially in patients with central lines.
- Underscores the need for prompt diagnosis and appropriate antifungal therapy, alongside device removal, for successful management.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The Central Dogma

